Antibody to high-molecular-weight kininogen effectively inhibits angiogenesis in tumor models July 19, 2001
Ortec's wound-healing product to be marketed as OrCel; FDA advisory panel recommends approval July 19, 2001
Synthetic low-molecular-weight thrombin inhibitor and oral prodrug profiled at ISTH meeting July 19, 2001
RSS